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Steady-state oxygenWe have developed a respiration chamber that allows intact cells to be studied under controlled oxygen (O2)
conditions. The system measures the concentrations of O2 and nitric oxide (NO) in the cell suspension, while
the redox state of cytochrome c oxidase is continuously monitored optically. Using human embryonic kidney
cells transfected with a tetracycline-inducible NO synthase we show that the inactivation of NO by
cytochrome c oxidase is dependent on both O2 concentration and electron turnover of the enzyme. At a high
O2 concentration (70 μM), and while the enzyme is in turnover, NO generated by the NO synthase upon
addition of a given concentration of L-arginine is partially inactivated by cytochrome c oxidase and does not
affect the redox state of the enzyme or consumption of O2. At low O2 (15 μM), when the cytochrome c
oxidase is more reduced, inactivation of NO is decreased. In addition, the NO that is not inactivated inhibits
the cytochrome c oxidase, further reducing the enzyme and lowering O2 consumption. At both high and low
O2 concentrations the inactivation of NO is decreased when sodium azide is used to inhibit cytochrome c
oxidase and decrease electron turnover.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Nitric oxide (NO) is a widespread biological mediator that plays a
role in a variety of cell functions [1]. Although the mechanism by
which NO is generated by the different NO synthases has been
elucidated in detail [2-5], the routes of its inactivation remain
controversial. Various possibilities have been suggested, the majority
involving interactions with either oxidants [6-10] or haem-containing
proteins [11-15]. The existence of an unidentiﬁed protein acting as a
sink for NO in brain tissue has also been postulated [16]. One potential
route of NO inactivation is by cytochrome c oxidase, the terminal
enzyme in the mitochondrial respiratory chain. This enzyme, which is
inhibited by NO, has the capacity to convert NO to nitrite (NO2−)
when the binuclear centre is predominantly oxidised and the enzyme
is in turnover [17-21]. Conversion of NO to NO2− has also been
demonstrated in cells [22].
We have previously shown, in intact cells, that the inactivation of
NO is critically dependent on the NO/oxygen (O2) ratio and have
suggested that at low O2 concentrations, when cytochrome c oxidase
is reduced, there is a diversion of NO towards the soluble guanylate
cyclase that might explain hypoxic vasodilation [23]. Our previous
studies were carried out in an O2-tight chamber, in which respiring
cells consumed O2 until they reached hypoxia [24]. This imposed
constraints on the experimental design, due to the progressive
decrease in O2 concentration in the cell suspension ([O2]) resulting: +44 20 7209 0470.
ll rights reserved.in a short observation period in which the experimental conditions
were constantly changing. In order to avoid these limitations we have
now developed a system which allows the [O2] to be controlled and
therefore facilitates the study of mitochondrial function in intact cells
at a steady [O2]. Here we show in intact cells that NO is converted to
NO2− at steady-state, physiological [O2]. These results conﬁrm
observations that indicate that the cytochrome c oxidase plays an
important role in regulating endogenous NO concentrations.
2. Materials and methods
2.1. Instrumentation
To enable us to study cells in a stable O2 environment we have
further developed our visible light spectroscopy (VLS) system [23,24]
to include a gas headspace within the measurement chamber. By
varying the partial pressure of O2 gas in the headspace we are able to
control its concentration in the liquid sample via O2 exchange
between the two phases. The system (Fig. 1) comprises a 10-mm
diameter quartz glass chamber surrounded by a water jacket heated
to 37 °C, mounted onto a Clark-type O2 electrode (Rank Brothers,
Bottisham, UK). A titanium plunger with a Viton O-ring holds an
electrode for NO measurements (ami600, Innovative Instruments,
USA) and contains channels to allow gas purging of the headspace and
the addition of reagents into the chamber. The chamber holds 1 ml of
cell suspension, with a headspace of 0.5 ml. A magnetic, glass-coated
stirrer, spinning at 750 rpm, is used to keep the cells in suspension and
to help minimise any O2 gradient within the liquid phase. The
Fig. 1. Diagram of the experimental apparatus. Input gases are humidiﬁed and mixed prior to entering the chamber through the plunger, which also holds the NO electrode. There is
an O2 electrode at the base, and optical ﬁbres are ﬂush with the outside of the chamber sides. MFC=mass ﬂow controller.
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mixture of nitrogen (N2) and O2 gas. The gases are bubbled through
water heated to 37 °C, prior to mixing, in order to humidify them (Fig.
1). The fractions of O2 and N2 in the gas mix (O2gas and N2gas) are set
by two mass ﬂow controllers (1179B, MKS Instruments, Germany).
When necessary the gas ﬂow can be turned off and the chamber
completely closed so that no headspace remains.
2.2. Measurement and control of oxygen
The [O2] depends on its relative supply to and removal from the
liquid phase. Oxygen is supplied by diffusion from the gas headspace
and is removed by cellular respiration, consumption by the O2
electrode and diffusion back into the headspace. In our system the net
ﬂux for a given gas, Jf, from the gas to liquid phase is given by the
equation:
Jf¼ mx CT − C
  ð1Þ
where mx is the mass transfer coefﬁcient, C is the measured liquid
phase dissolved gas concentration and C⁎ is the concentration in the
solution when in equilibrium [25,26]. The O2 mass transfer coefﬁcient
for our system, determined experimentally by generating a step
change in the partial pressure of O2 in the gas phase and measuring
the temporal change in [O2], was found to be 0.0053±0.0006 s−1. We
control Jf by changing the ratio of O2gas and N2gas and in doing so we
can control [O2]. When Jf matches the cellular oxygen consumption a
steady state [O2] can be maintained. Increasing or decreasing Jf
relative to oxygen consumption leads to a raising or lowering of [O2],
respectively.
2.3. Measurement of NO
The NO electrode is calibrated daily by reducing a known
quantity of NO2− to NO in a reaction with 100 mM H2SO4 and
10 mM KI. Typically the electrode sensitivity was over 120 pA·nM−1.
The time response of the electrode was measured to be 13.5±1.0 s.
There are two main, non-cellular routes for NO to be removed from
the liquid phase: diffusion into the gas headspace and NO
autoxidation. The NO partial pressure in the gas phase is zero,
since the headspace is continuously purged with N2 and O2 gases.
Therefore, from the equation in Section 2.2, applied to NO gas (withC⁎=0), the diffusion of NO out of the liquid phase will be
proportional to its concentration in the liquid phase, [NO].
Autoxidation of NO is proportional to [O2] and the square of the
[NO] [27]. In order to assess the contributions of autoxidation and
diffusion to the rate of NO removal from the liquid phase in the
absence of cells we used the NO donor diethylamine NO (DEANO;
t½=2 min) in Hanks-VLS solution (20 mM HEPES, 5.5 mM D-glucose,
5.37 mM KCl, 1.26 mM CaCl2, 0.5 mMMgCl2, 0.4 mMMgSO4, 137 mM
NaCl, 4.2 mM NaHCO3, 0.34 mM Na2HPO4 and 1% dialysed heat-
inactivated foetal bovine serum (HI-FBS)) and measured [NO] as a
function of time at different constant [O2]. After addition of 1 μM
DEANO there was an initial, sharp rise in [NO] followed by a more
gradual fall as production stopped and NO was removed from the
liquid phase (Supplementary Fig. 1). At O2 concentrations between 10
and 85 μM neither the rate of NO release nor the peak concentration
exhibited any signiﬁcant dependence on [O2]. The maximum NO
concentration reached in these measurements (Supplementary Fig. 1)
was higher than that reached in other experiments described in this
paper, but was still in the nM range. This indicates that, at the lower
concentrations of NO and at the [O2] used in other experiments in this
study, the contribution of autoxidation to the rate of removal of NO is
small relative to that of diffusion. Therefore, since autoxidation did not
signiﬁcantly affect the results it was excluded from the analysis.
2.4. Measurement of cytochrome redox states
Spectroscopic measurements are made with a Shamrock 303i
spectrometer ﬁtted with a 600 lines·mm−1 grating and a charge-
coupled device (CCD) camera (Andor Technology, UK). A broadband
light source (77501 LOT Oriel, UK) illuminates the liquid phase
through an optical ﬁbre that is ﬂush with the outside of the glass
chamber. A band-pass optical ﬁlter (KG5T, UQG Optics, UK) blocks out
unwanted light and heat. Transmitted light is collected by a second
ﬁbre, also ﬂush with the outside of the chamber, and passed to the
spectrometer and CCD for detection, Fig. 1.
Changes in the redox state of haem a and haem a3 are derived from
changes in the measured optical attenuation, as described previously
[28]. For simpliﬁcation, throughout this paper we refer to changes in
the redox states of haems a and a3 as changes to the redox state of
cytochrome c oxidase. Brieﬂy, the change in attenuation is converted
to a change in redox state through a least-squares ﬁtting of the
difference (oxidised minus reduced) absorption spectrum of
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absorption spectrum is a combination of the difference spectra of
haem a (which contributes 80–90% of the total signal) and haem a3
[24]. In some of our measurements we used sodium azide as an
inhibitor of cytochrome c oxidase activity that binds only to the
oxidized catalytic centre, the species responsible for conversion of NO
to NO2 −. Azide binding to the oxidized haem a3-CuB causes a
blueshift (∼2 nm) in the α-peak of the absorption spectrum [29] and it
should be noted that this is not accounted for in the ﬁtting procedure.
The redox state is expressed as a percentage, with 100% being the fully
oxidised state reached after addition of 1 μMmyxothiazol to cells at high
[O2] and 0% being the reduced state achieved under closed chamber
anoxic conditions, determined separately. Therefore, reference to a
percentage increase in the redox state of cytochrome c oxidase indicates
that it has becomemore oxidised, whilst a decrease refers to reduction.
2.5. Cell culture and induction of Tet-iNOS-293 cells
We used a tetracycline-inducible human embryonic kidney cell
line (Tet-iNOS-293) that has been transfected to stably express nitric
oxide synthase upon induction with tetracycline, as described by
Mateo et al. [30]. Tet-iNOS-293 cells were cultured in T-175 ﬂasks
with phenol red-free Dulbecco's modiﬁed eagles medium (DMEM)
containing 25 mM D-glucose, 4 mM glutamine, 15 μg·ml−1
blasticidine, 200 μg·ml−1 hygromycin B and 10% (v/v) of HI-FBS, as
previously described [30]. The cell line produced maximal NO
synthase expression after incubation in induction medium (DMEM,
10% HI-FBS, 1.5 μg·ml−1 tetracycline and 500 μM S-ethylisothiourea
(S-EITU)) for 15 h. The addition of S-EITU prevents generation of NO
by the NO synthase. Cells were harvested by trypsinisation between
15 and 20 h after induction, centrifuged at 115×g for 10 min and re-
suspended in Hanks-VLS solution [28] at a concentration of ∼5×106
cells·ml−1. The cells were placed in a conical ﬂask in a shaking water
bath (80 rpm, 37 °C) for 1 h to remove the S-EITU used in the
induction medium. They were then centrifuged again and re-
suspended at 1–2×107 cells·ml−1 in Hanks-VLS solution. At this
stage, cell viability, measured by the Trypan Blue exclusion method,
was above 95%. The cells were then returned to the water bath where
they were kept for a minimum of 1 h more. Post-experimental
counting of each cell sample was carried out using a Coulter Counter
(Z series, Beckman Coulter, FL) as previously described [28].
L-arginine, S-EITU, tetracycline and trypsin inhibitor were from
Sigma. Blasticidin was from Calbiochem. All other tissue culture
solutions and media, as well as hygromycin B, were from Invitrogen.
DEANO was from Alexis Biochemicals.
2.6. Experimental procedure
The procedure used in each experiment was essentially the same.
Cells were prepared in bulk as described in Section 2.5. A 1-ml aliquot
of cell suspension was then placed in the chamber and the plunger
inserted, after which the gas headspace was continuously purgedwith
50 ml·min−1N2 and O2 gas mix. Initially O2gas was set to 0.5%, which,
along with O2 consumption by the cells, resulted in a rapid fall in [O2]
from an initial value of ∼180 μM. When the [O2] was close to the
required concentration, O2gas was increased so that the O2 partial
pressure in the headspace was high compared to that in cell
suspension, resulting in a reversal in the direction of O2 diffusion.
By adjusting O2gas appropriately it was possible to control the
diffusion rate so that it matched the cellular consumption rate, thus
achieving a steady-state [O2]. This procedure did not usually take
longer than 5 min. Once the required [O2] was reached, no further
changes to O2gas were made. The cell suspension was allowed to
stabilise for a further 5 min prior to the addition of L-arginine.
Throughout the whole experiment [O2], [NO] and cytochrome c
oxidase redox state were monitored once every second. In someexperiments 500 μM sodium azide was added to the cell suspension
when the [O2] reached 100 μM during the initial purging process,
while the cytochromes were still predominantly oxidised.
2.7. Data analysis
The area under the curve (AUC) of plots of NO concentration
against time was used to quantify NO release in the experiments
described in Section 3.3. The AUC was calculated by numerically
integrating each NO trace over a period of 15 min, from the time of
L-arginine addition, using the trapezoidal method (OriginPro 8,
OriginLab, USA), with units of μM·min. All values of NO concentration
are given from a baseline taken at the point of addition of L-arginine.
Means±standard deviations were calculated for quantitative
analysis of all data, with the number of samples (n) in each
experimental group indicated in the associated text. The two-sample
-test was used to determine statistically signiﬁcant differences
between means, with a signiﬁcance level of Pb0.05.
3. Results
3.1. Concentration-dependent generation of NO from L-arginine
We investigated the release of NO and its subsequent effect on the
cytochrome c oxidase redox state and [O2] in induced Tet-iNOS-293
cells after the addition of different concentrations of L-arginine. The
cells were collected as described in Section 2.5. After being placed in
the chamber the cells were stabilised at a constant [O2] of 70.3±2.0 μM
(n=32) for 5min. L-arginine (1–500 μM)was then added, resulting in a
concentration-dependent release of NO within seconds from the cells.
The amounts of NO released after the addition of 5, 10, 50 and 100 μM
L-arginine are shown in Fig. 2A (upper panel). Both the amount of NO
released and the time taken for the release to reach a peak were
dependent on the concentration of L-arginine added (Fig. 2B and not
shown; 8 concentrations, each n=4).
At concentrations of 10 μM L-arginine or greater the release of NO
was accompanied by a concentration-dependent reduction in the
redox state of cytochrome c oxidase (Fig. 2A, centre panel). At lower L-
arginine concentrations (b10 μM) no such change occurred. As the
[NO] increased (at concentrations of L-arginine N10 μM) there was
also a decrease in O2 consumption by the cells, resulting in an increase
in the [O2] in the chamber (Fig. 2A, lower panel). For all subsequent
measurements of the inactivation of NO by cytochrome c oxidase 5 μM
L-arginine was used, since this generated themaximum concentration
of NO that did not affect the redox state of cytochrome c oxidase (or
O2 consumption) at 70 μM O2.
3.2. O2-dependent generation of NO from NO synthase
We investigated the kinetics of NO release from NO synthase in
cells in which mitochondrial respiration was inhibited with sodium
azide to prevent NO inactivation and avoid competition for O2 as a
substrate. Cells were placed in the chamber and 500 μM sodium azide
was added when [O2] reached 100 μM during the initial purging
process. They were then stabilised at various constant [O2] for 5 min
before the addition of excess (1 mM) L-arginine. The concentration of
NO released was recorded and the maximal rate of release, which
occurred immediately (within 20–30 s) after L-arginine addition, was
found to be [O2]-dependent (Fig. 3). Data were taken on 5 different
days. Each data set was corrected for the time response of the NO
electrode and ﬁtted to the Michaelis–Menten equation. No account
has been taken of NO diffusion into the headspace as this is low during
the short measurement period of these experiments. Similarly, [O2] is
assumed to be constant during this time. The NO synthase was found
to have a mean apparent Km for O2 of 16.1±4.1 μM and a Vmax of
20.6±5.0 nM·s−1 (n=5).
Fig. 3. Initial rate of NO release after addition of 1 mM L-arginine to cells in which
mitochondrial respiration has been inhibited. Data were obtained on ﬁve different days.
The dotted line is a plot of theMichaelis–Menten equation using Km=16.1±4.1 μMand a
Vmax of 20.6±5.0 nM·s−1.
Fig. 2. Concentration-dependent generation of NO from L-arginine. (A) Effect of 5
(black), 10 (red), 50 (green) and 100 (blue) μM L-arginine on release of NO (upper
panel), cytochrome c oxidase redox state (% oxidised, centre panel) and [O2] (lower
panel) in Tet-iNOS-293 cells. Trace representative of 4 experiments. Prior to addition of
L-arginine [O2] was stabilised at 70.3±2 μM (n=32). (B) The peak concentration of NO
released (±standard deviation) as a function of L-arginine added (n=4).
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We have previously demonstrated in an O2-tight system that NO is
inactivated in respiring cells when cytochrome c oxidase is in
turnover, and that the degree of inactivation decreases as the enzyme
becomes more reduced at low [O2] [23]. Using our present system we
carried out experiments in which 5 μM L-arginine was added to cells
maintained at either 70 or 15 μM O2 in the absence or presence of
sodium azide.
In cells held at a steady concentration of 70 μMO2 the cytochrome
c oxidasewas 83.7±1.6% oxidised (n=8). Addition of 5 μM L-arginine
caused the release of NO, which reached a peak after approximately
2 min and then declined (Fig. 4A, upper panel). This concentration of
L-arginine had no measurable effect on either the redox state of
cytochrome c oxidase (Fig. 4A, centre panel) or the [O2] (Fig. 4A,
lower panel). In contrast, in cells held at a steady concentration of
15 μM O2 the cytochrome c oxidase was 77.5±1.8% oxidised
(n=8). The difference in redox state between 70 and 15 μM O2 was
small but signiﬁcant (Pb0.05) and at both concentrations the
enzyme was predominantly oxidised. In cells held at concentrations
above 15 μM O2 any change in [O2] resulted in only a small change in
redox state. However, in cells where O2 fell below 15 μM any further
reduction in [O2] caused a pronounced change in redox state, with
the enzyme becoming predominantly reduced. Thus, it is at
concentrations at and below 15 μM O2 that we expect to see large
changes in NO metabolism and other mitochondrial activity, as has
been suggested by our previous results [23]. In cells held at a steadyconcentration of 15 μM O2 the addition of 5 μM L-arginine resulted in
the release of NO (Fig. 4B, upper panel), as well as a further,
signiﬁcant (Pb0.05), decrease in the redox state of cytochrome c
oxidase (Fig. 4B, centre panel) to 68.7±5.4% (n=8), due to
inhibition of the enzyme by NO. This inhibition decreased the
consumption of O2, as demonstrated by the increase in [O2]
following the NO release (Fig. 4B, lower panel).
The addition of 500 μM sodium azide at 100 μM O2 during the
initial purging process resulted in a maximal reduction in cytochrome
c oxidase redox state. At stable [O2] of both 70 and 15 μM the addition
of 5 μM L-arginine caused a greater and more sustained release of NO
(Fig. 4C and D, upper panels) than was observed in the absence of
sodium azide. However, this release of NO had no further effect on the
redox state of cytochrome c oxidase, nor did it affect the [O2] (Fig. 4C
and D, centre and lower panels).
The effect of the cytochrome c oxidase redox state and electron
turnover on NO inactivation was determined by quantifying the
amount of NO released upon addition of L-arginine, using the AUC (see
Section 2.7) for NO concentration plotted against time. Fig. 5 shows
the AUCs at 70 and 15 μM O2 in the absence and presence of sodium
azide. At 70 μM O2 the AUC was 1.18±0.53 μM·min (n=8), while at
15 μM O2 it was signiﬁcantly higher (Pb0.05) at 2.28±0.98 μM·min
(n=8). In the presence of sodium azide, when cytochrome c oxidase
was not in turnover, the AUCs were signiﬁcantly higher (Pb0.05) than
in the absence of sodium azide at both 70 and 15 μM O2, being
4.98±2.61 μM·min (n=8) and 6.47±2.25 μM·min (n=8), respec-
tively. The AUCs determined in the presence of sodium azide at 70 and
15 μM O2 were not signiﬁcantly different from one another. Thus, for
an L-arginine concentration of 5 μM, the activity of NO synthase had
not signiﬁcantly changed with [O2], suggesting that, in this case,
L-arginine is the limiting factor in NO synthesis.
4. Discussion
We have developed our VLS system to include a gas delivery
mechanism so that we are able to control the [O2] inside the chamber.
This has allowed us to investigate the interaction between NO and O2
at the catalytic centre of cytochrome c oxidase under steady-state [O2]
conditions.
We studied the release of NO and the redox state of cytochrome c
oxidase at 70 μM [O2] in Tet-iNOS-293 intact cells, in which NO is
generated by a tetracycline-inducible NO synthase upon addition of
L-arginine. Low L-arginine concentrations (b10 μM) resulted in the
release of small amounts of NO without affecting the cytochrome
redox state or steady-state [O2]. However, higher concentrations of
L-arginine generated more NO, which led to a decrease in the redox
state of cytochrome c oxidase and an inhibition of cellular
respiration. These results are in agreement with our previous
Fig. 4. Effect of [O2] and sodium azide (NaN3) on cytochrome c oxidase. The measured [NO] (upper panel), cytochrome c oxidase redox state (% oxidised, centre panel) and [O2]
(lower panel) are shown for cells at an initial concentration of 70 μM (A, C) and 15 μM O2 (B, D) in the absence (A, B) and presence (C, D) of 500 μM sodium azide. In all cases
5 μM L-arginine was added at t=0 min. Trace representative of 8 experiments.
Fig. 5. Effect of [O2] and sodium azide on NO metabolism. The NO release, quantiﬁed as
the AUC, calculated over 15 min after addition of 5 μM L-arginine at 70 and 15 μMO2, in
the absence (light grey) and presence (dark grey) of 500 μM sodium azide. (⁎)
Signiﬁcant (Pb0.05) difference from the respective control, (#) signiﬁcant (Pb0.05)
difference from control at 70 μM O2 (n=8).
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demonstrated that, in the presence of low NO concentrations
interacting with the enzyme, cytochrome c oxidase can recruit
extra capacity to maintain O2 consumption [28]. Once all the
available capacity has been utilised, further increases in [NO] result
in the reversible inhibition of cytochrome c oxidase. This inhibition
leads to a fall in the O2 consumption rate, which was seen here as a
transient rise in the measured [O2] after addition of L-arginine.
Interestingly, the total amount of NO released as a function of
L-arginine concentration in these experiments was much higher than
that obtained in our previous experiments with a closed chamber [23].
In those experiments all O2was consumedwithin∼5–10min. The lack
of O2, which is a substrate of NO synthase, eventually restricted NO
production, thus limiting the total amount of NO that could be
produced. In our current experiments there is no such limit and NO
synthase can continue to generate NO as long as L-arginine is still
available.
In order to determine whether the different [O2] studied in our
experiments affected the rate of generation of NO from NO synthase
we measured the rate of NO release from cells in which respiration
had been inhibited by the addition of sodium azide. In our study
application of Michaelis–Menten kinetics gave an apparent Km of O2
for NO synthase of 16.1±4.1 μM. The cells were exposed to the
different [O2] for only the period of experiment itself (b20 min),
therefore the changes in NO production observed were unlikely to be
a result of changes in concentration or expression of NO synthase or
other factors thatmay affect the activity of the enzyme over the longer
term. In comparable experiments with RAW 264.7 cells, also
subjected to a brief exposure to a given [O2], a Km of 31 μM has
been reported for murine inducible NO synthase [31]. For cellsexposed for longer periods to different [O2] the apparent Km has been
measured at 137 µM [32] and estimated to be 14 Torr (~17.5 µM O2)
at the cell surface [33]. Experiments in the isolated enzyme [34] and
simulations of NO production by induced NO synthase [35] have
shown that the apparent Km depends on the build up of NO, which
itself will inhibit the activity of NO synthase. In our experiments cells
were incubated in the absence of L-arginine and in the presence of
SEITU in order to suppress the production and build up of NO. During
themeasurement period itself, and after the addition of L-arginine, the
highest [NO] reached was not sufﬁcient to inhibit the enzyme [36].
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by cytochrome c oxidase is determined by the redox state of the
enzyme in turnover [23]. Herewe have seen that signiﬁcantlymore NO
was released (as quantiﬁed by theAUC) fromuninhibited cells at 15 μM
O2, where the cytochrome c oxidase redox state was 77.5±1.8%, than
at 70 μM O2, where it was 83.7±1.6%, indicating that a more oxidised
enzyme inactivates more NO. This result was not due to different
amounts of NO being generated at 70 and 15 μMO2 since cells in which
the cytochrome c oxidase had been inhibited with sodium azide
released the same amount of NO at both [O2]. At 15 μM O2 the NO
inhibited the cytochrome c oxidase, causing a further reduction of its
redox state to 68.7±5.4% and inhibition of respiration. This leads to a
decrease in the inactivation of NO by cytochrome c oxidase, effectively
diverting NO towards other targets inside and outside the cell [23] and
providing a mechanism whereby the redox state of cytochrome c
oxidase at low [O2] may inﬂuence physiological parameters such as
vasodilation. This is in contrast with studies in which an increase in
[NO] at low [O2]was also observed, butwas attributed to the conversion
of NO2 − to NO by either cytochrome c oxidase itself [37,38],
cytochrome bc1 (mitochondrial complex III) [39,40] or other cytosolic
enzymes [41-43] under hypoxic conditions. Interestingly, a recent
study that modelled themetabolism of NO by the oxidised cytochrome
c oxidase suggested that the rate of this reaction is higher, by anorder of
magnitude, than other modes of NO inactivation in mitochondria [44].
We then investigated the effect of turnover of cytochrome c
oxidase on the inactivation of NO. Addition of sodium azide at 100 μM
O2, when cytochrome c oxidase is mainly oxidised, stopped its
turnover. At both 70 and 15 μMO2 addition of 5 μM L-arginine resulted
in a release of NO that was signiﬁcantly greater than that released by
their respective controls. This indicates that the enzyme, in turnover,
plays a major role in the cellular inactivation of NO.
In summary, we have designed a respiration chamber in which the
[O2] can be controlled and have used it to study the inactivation of NO
by cytochrome c oxidase in intact cells. This system allows us to study
the kinetic parameters of enzymes such as NO synthase in vivo. Our
results demonstrate that NO inactivation is dependent on both the
electron turnover and redox state of cytochrome c oxidase, further
indicating that this enzyme is an important biological regulator of NO
concentrations in cells and tissues.
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